Issues and challenges with antithrombotic therapy in diabetic patients with acute coronary syndromes |
| |
Authors: | Gregory W Barsness MD |
| |
Institution: | (1) Mayo Clinic and Foundation, 200 1st Street SW, 55905 Rochester, MN, USA |
| |
Abstract: | Diabetes mellitus is associated with significant morbidity and mortality in the setting of acute coronary syndromes. This
increased risk is attributable, in large part, to the derangements in coagulation that can accompany the diabetic disease
state. Patients with diabetes mellitus have disturbances in endothelial function, platelet function, and coagulation factors.
Until recently, there has been little direct exploration of therapeutic measures to improve outcome specifically among diabetic
patients with acute coronary syndromes. Fortunately, antithrombotic therapies that have proven benefit in the general population
also seem to be beneficial among patients with diabetes, although optimal dosing for improved safety and efficacy in this
population has yet to be established for many of these agents. Primary prevention strategies and strict attention to risk
factor modification hold the greatest promise for improving long-term outcome. |
| |
Keywords: | |
本文献已被 PubMed SpringerLink 等数据库收录! |
|